36Medicines listed in the pharmaceutical benefits scheme

36 Medicines listed in the pharmaceutical benefits scheme

(1) If: (a) a pharmacy marketing group publishes or disseminates a price information list that includes price information for a medicine listed in the pharmaceutical benefits scheme that is a brand premium or therapeutic group premium; and (b) the price information list mentioned in paragraph (a) includes price information for the pharmacy marketing group’s own generic medicine that is listed in the pharmaceutical benefits scheme; then the price information list must also include price information for at least one other bench-mark price brand of that medicine, where such medicine exists. (2) A price information list that includes a medicine listed in the pharmaceutical benefits scheme must clearly: (a) indicate that the medicine is listed in the pharmaceutical benefits scheme; and (b) specify the total purchase price with reference to the general price or concessional price or both. (3) A price information list that includes a medicine listed in the pharmaceutical benefits scheme must indicate that the purchase price: (a) is subsidised by the Australian Government; and (b) only applies when the medicine is prescribed for the medical conditions listed in the pharmaceutical benefits scheme schedule for that medicine. (4) A price information list may include a statement that particular medicines are listed in the pharmaceutical benefits scheme only in relation to certain diseases, conditions, ailments or defects (without specifying those diseases, conditions, ailments or defects).